|
|
Blood, 15 October 2005, Vol. 106, No. 8, pp. 2827-2836.
Prepublished online as a Blood First Edition Paper on June 28, 2005; DOI 10.1182/blood-2005-01-0358.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia
Sigal Gery,
Adrian F. Gombart,
William S. Yi,
Chloe Koeffler,
Wolf-K. Hofmann, and
H. Phillip Koeffler
From the Cedars-Sinai Medical Center, Division of Hematology/Oncology, University of California (UCLA) School of Medicine, Los Angeles, CA; and the Department of Hematology and Oncology and Transfusion Medicine, University Hospital "Benjamin Franklin," Berlin, Germany.
CCAAT/enhancer-binding proteins (C/EBPs) are a family of transcription factors that regulate cell growth and differentiation in numerous cell types. To identify novel C/EBP-target genes, we performed transcriptional profiling using inducible NIH 3T3 cell lines expressing 1 of 4 members of the C/EBP family. Functional analysis revealed a previously unknown link between C/EBP proteins and circadian clock genes. Our microarray data showed that the expression levels of 2 core components of the circadian network, Per2 and Rev-Erb , were significantly altered by C/EBPs. Recent studies suggested that Per2 behaves as a tumor suppressor gene in mice. Therefore, we focused our additional studies on Per2. We showed that Per2 expression is up-regulated by C/EBP and C/EBP . Per2 levels were reduced in lymphoma cell lines and in acute myeloid leukemia (AML) patient samples. In addition, we generated stable K562 cells that expressed an inducible Per2 gene. Induction of Per2 expression resulted in growth inhibition, cell cycle arrest, apoptosis, and loss of clonogenic ability. These results suggest that Per2 is a downstream C/EBP-target gene involved in AML, and its disruption might be involved in initiation and/or progression of AML. (Blood. 2005; 106:2827-2836)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. E. Hoffman, T. Zheng, R. G. Stevens, Y. Ba, Y. Zhang, D. Leaderer, C. Yi, T. R. Holford, and Y. Zhu
Clock-Cancer Connection in Non-Hodgkin's Lymphoma: A Genetic Association Study and Pathway Analysis of the Circadian Gene Cryptochrome 2
Cancer Res.,
April 15, 2009;
69(8):
3605 - 3613.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Chen-Goodspeed and Cheng Chi Lee
Tumor Suppression and Circadian Function
J Biol Rhythms,
August 1, 2007;
22(4):
291 - 298.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. Johung, E. C. Goodwin, and D. DiMaio
Human Papillomavirus E7 Repression in Cervical Carcinoma Cells Initiates a Transcriptional Cascade Driven by the Retinoblastoma Family, Resulting in Senescence
J. Virol.,
March 1, 2007;
81(5):
2102 - 2116.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Gery, N. Komatsu, N. Kawamata, C. W. Miller, J. Desmond, R. K. Virk, A. Marchevsky, R. Mckenna, H. Taguchi, and H. P. Koeffler
Epigenetic Silencing of the Candidate Tumor Suppressor Gene Per1 in Non-Small Cell Lung Cancer
Clin. Cancer Res.,
March 1, 2007;
13(5):
1399 - 1404.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. H. Ko and J. S. Takahashi
Molecular components of the mammalian circadian clock
Hum. Mol. Genet.,
October 15, 2006;
15(suppl_2):
R271 - R277.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Brown, C. R. Wilkinson, S. R. Waterman, C. H. Kok, D. G. Salerno, S. M. Diakiw, B. Reynolds, H. S. Scott, A. Tsykin, G. F. Glonek, et al.
Genetic regulators of myelopoiesis and leukemic signaling identified by gene profiling and linear modeling
J. Leukoc. Biol.,
August 1, 2006;
80(2):
433 - 447.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
